Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$260,747,707
+$105,673,566 QoQ
Shares Held
217,393
+28.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#232
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $3,146,467,914 across 15 Drug Manufacturers - General names. LLY ranks #7 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
21,818,803 | $525,396,775 | |
| 2 | AMGN |
Amgen Inc
|
1,131,395 | $409,700,757 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,991,633 | $377,962,913 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,981,822 | $344,672,583 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,591,856 | $333,053,496 | |
| 6 | JNJ |
Johnson & Johnson
|
1,284,877 | $326,320,211 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
217,393 | $260,747,707 | |
| 8 | ABBV |
AbbVie Inc.
|
800,818 | $201,517,841 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $260,747,707 | 217,393 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $155,074,141 | 168,601 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $179,789,682 | 167,296 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $58,332,113 | 76,451 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $106,071,426 | 136,071 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $94,996,994 | 115,021 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $80,706,424 | 104,542 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $78,602,368 | 88,722 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $79,105,766 | 87,373 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $63,571,779 | 81,716 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $50,641,175 | 86,875 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $243,463,840 | 453,268 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $223,856,347 | 477,326 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $202,500,006 | 589,657 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $241,315,014 | 659,619 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $235,724,736 | 729,008 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $71,743,993 | 221,275 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $105,000,710 | 366,661 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $101,556,978 | 367,667 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $97,196,727 | 420,674 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $89,233,703 | 388,784 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $71,206,816 | 381,152 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $286,067,806 | 1,694,313 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $231,754,914 | 1,565,700 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $181,732,483 | 1,106,910 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $122,006,736 | 879,518 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||